3 hours Enanta Pharmaceuticals (NASDAQ:ENTA) Receives Market Outperform Rating from JMP Securities MarketBeat
JMP Securities reissued a “market outperform” rating and issued a $22.00 price objective on shares of Enanta Pharmaceuticals in a report on Wednesday.